Keeps Biopharma Inc. Logo

Keeps Biopharma Inc.

Develops cancer therapies and obesity drugs; manufactures industrial and cleanroom products.

256940 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 화성시 동탄면 동탄산단10길 52, 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Keeps Biopharma Inc. is a company with diversified operations in biopharmaceuticals and industrial manufacturing. The biopharmaceutical division focuses on the research and development of biomarker-driven targeted therapies for women's cancers, including ovarian, endometrial, and triple-negative breast cancer. The company is also advancing an oral obesity drug, which is reportedly undergoing primate trials. Operating under its former name, KPS Corp, the company's industrial segment manufactures and sells mechanical equipment for the flat panel display industry and produces cleanroom consumables such as wipers and adhesive rolls.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Keeps Biopharma Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-02 00:00
M&A Activity
주요사항보고서(유형자산양수결정)
Korean 15.9 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.8 MB

Automate Your Workflow. Get a real-time feed of all Keeps Biopharma Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Keeps Biopharma Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Pluri Inc. Logo
Develops placenta-based cell therapeutics using a proprietary 3D cell-expansion platform.
Israel PLUR
A global supplier of generic APIs using AI to accelerate drug development.
South Korea 041910
Poltreg S.A. Logo
Pioneering T-regulatory cell therapies for autoimmune diseases like diabetes, MS, and ALS.
Poland PTG
PolyPeptide Group AG Logo
A global CDMO specializing in peptide and oligonucleotide APIs for pharma and biotech partners.
Switzerland PPGN
Develops sensitive point-of-care biomarker diagnostics for human and animal health.
South Korea 335810
A global CDEMO offering end-to-end solutions for antibody therapeutics and biologics.
South Korea 334970
Develops affordable biosimilars and novel antibody drugs for life-threatening diseases.
Singapore 950210
Develops protein-based immunotherapies for metabolic diseases, immune disorders, and cancer.
South Korea 296160
PROTEINA CO.,LTD. Logo
A biotech firm specializing in proteomics for drug discovery and diagnostics in oncology.
South Korea 468530
PROTIA INC. Logo
Develops IVD kits and instruments for allergy, POCT, infectious & autoimmune diseases.
South Korea 303360

Talk to a Data Expert

Have a question? We'll get back to you promptly.